| 1 |
Zheng L, Zhang L, Tang L, Huang D, Pan D, Guo W, He S, Huang Y, Chen Y, Xiao X, Tang B, Chen J. Gut microbiota is associated with response to (131)I therapy in patients with papillary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2023;50:1453-65. [PMID: 36512067 DOI: 10.1007/s00259-022-06072-5] [Reference Citation Analysis]
|
| 2 |
Eladwy RA, Vu HT, Shah R, Li CG, Chang D, Bhuyan DJ. The Fight against the Carcinogenic Epstein-Barr Virus: Gut Microbiota, Natural Medicines, and Beyond. Int J Mol Sci 2023;24. [PMID: 36675232 DOI: 10.3390/ijms24021716] [Reference Citation Analysis]
|
| 3 |
Wu H, Chen X, Zhang S, Li J. Gut Microbiota, the Potential Biological Medicine for Prevention, Intervention and Drug Sensitization to Fight Diseases. Nutrients 2022;14:4220. [DOI: 10.3390/nu14204220] [Reference Citation Analysis]
|
| 4 |
Wang B, Tang X, Mao B, Zhang Q, Tian F, Zhao J, Cui S, Chen W. Anti-aging effects and mechanisms of anthocyanins and their intestinal microflora metabolites. Crit Rev Food Sci Nutr 2022;:1-17. [PMID: 36128763 DOI: 10.1080/10408398.2022.2123444] [Reference Citation Analysis]
|
| 5 |
Peng Y, Liu F, Qiao Y, Wang P, Ma B, Li L, Si C, Wang X, Zhang M, Song F. Association of abnormal bowel health with major chronic diseases and risk of mortality. Ann Epidemiol 2022;75:39-46. [PMID: 36116757 DOI: 10.1016/j.annepidem.2022.09.002] [Reference Citation Analysis]
|
| 6 |
Jaye K, Chang D, Li CG, Bhuyan DJ. Gut Metabolites and Breast Cancer: The Continuum of Dysbiosis, Breast Cancer Risk, and Potential Breast Cancer Therapy. Int J Mol Sci 2022;23:9490. [PMID: 36012771 DOI: 10.3390/ijms23169490] [Reference Citation Analysis]
|
| 7 |
Jaye K, Li CG, Chang D, Bhuyan DJ. The role of key gut microbial metabolites in the development and treatment of cancer. Gut Microbes 2022;14:2038865. [PMID: 35220885 DOI: 10.1080/19490976.2022.2038865] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 8 |
Wu R, Shen Q, Li P, Shang N. Sturgeon Chondroitin Sulfate Restores the Balance of Gut Microbiota in Colorectal Cancer Bearing Mice. Int J Mol Sci 2022;23:3723. [PMID: 35409083 DOI: 10.3390/ijms23073723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Fidelito G, Watt MJ, Taylor RA. Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality? Front Oncol 2022;11:778761. [DOI: 10.3389/fonc.2021.778761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
He L, Zhong Z, Chen M, Liang Q, Wang Y, Tan W. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers. Front Pharmacol 2022;12:775084. [DOI: 10.3389/fphar.2021.775084] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Ciernikova S, Sevcikova A, Kasperova B, Drgona L, Mego M. Targeting the Gut Microbiome in Cancer Treatment. Handbook of Cancer and Immunology 2022. [DOI: 10.1007/978-3-030-80962-1_263-1] [Reference Citation Analysis]
|
| 12 |
Chen G, Han Y, Zhang H, Tu W, Zhang S. Radiotherapy-Induced Digestive Injury: Diagnosis, Treatment and Mechanisms. Front Oncol 2021;11:757973. [PMID: 34804953 DOI: 10.3389/fonc.2021.757973] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
